Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Im trying to make the hl2 beta storyline like a novel using things like the Marc Laidlaw scripts, concept art, leaked maps, and mods to try and make it both accurate and fill in grey areas where there is little to none information on those areas. I want to know if its going in the right direction or if it needs certain changes. Please be honest ...

  2. Hace 4 horas · From legendary storyteller and master of short fiction Stephen King comes an extraordinary new collection of twelve short stories, many never-before-published, and some of his best EVER.“You like it darker? Fine, so do I,” writes Stephen King in the afterword to this magnificent new collection of twelve stories that delve into the darker part of life—both metaphorical and literal. King ...

  3. Hace 5 días · APG777 is a novel, subcutaneous half-life extended monoclonal antibody targeting IL-13 for the potential treatment of atopic dermatitis (AD). In head-to-head preclinical studies, ...

  4. Hace 1 día · Chimamanda Ngozi Adichie (/ ˌ tʃ ɪ m ə ˈ m ɑː n d ə ə ŋ ˈ ɡ oʊ z i ə ˈ d iː tʃ i. eɪ / ⓘ; born 15 September 1977) is a Nigerian writer, novelist, poet, essayist, and playwright of postcolonial feminist literature and public speaker. She is the author of the award-winning novels Purple Hibiscus (2003), Half of a Yellow Sun (2006) and Americanah (2013).

  5. Hace 1 día · In the video game Half-Life (1998), hostile alien creatures arrive on Earth through a portal after a scientific experiment goes wrong.

  6. Hace 4 días · APG777 is a novel, subcutaneous half-life extended monoclonal antibody targeting IL-13 for the potential treatment of atopic dermatitis (AD). In head-to-head preclinical studies, APG777 showed equivalent or better potency to lebrikizumab in the inhibition of IL-13 signaling.

  7. Hace 6 días · APG777 is a novel, subcutaneous half-life extended monoclonal antibody targeting IL-13 for the potential treatment of atopic dermatitis (AD). In head-to-head preclinical studies, ...